Dean Investment Associates’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-282,226
Closed -$5.46M 202
2017
Q4
$5.46M Buy
282,226
+150,016
+113% +$3.33M 0.83% 32
2017
Q3
$3.17M Sell
132,210
-52,645
-28% -$1.16M 0.48% 102
2017
Q2
$3.82M Buy
184,855
+23,085
+14% +$462K 0.58% 85
2017
Q1
$3.36M Buy
161,770
+13,720
+9% +$298K 0.56% 92
2016
Q4
$3.31M Buy
148,050
+34,005
+30% +$688K 0.57% 90
2016
Q3
$2.18M Buy
114,045
+45,926
+67% +$846K 0.41% 105
2016
Q2
$1.27M Buy
+68,119
New +$1.3M 0.25% 110

Other funds holding ADTN

Dean Investment Associates's ADTN Position: Q1 2018 in Review

Dean Investment Associates sold out of Adtran (ADTN) in Q1 2018, closing a stake of 282,226 shares — an estimated $5.46M sold.

Dean Investment Associates first reported a position in ADTN in Q2 2016 and held it in 7 quarters. The position peaked at $5.46M in Q4 2017. 158 funds tracked by Wall St. Rank hold ADTN as of Q1 2018.

  • Dean Investment Associates reported no remaining Adtran position as of Q1 2018 after selling out during the quarter.
  • Dean Investment Associates sold 282,226 Adtran shares in Q1 2018, an estimated $5.46M.
  • Dean Investment Associates first reported a position in Adtran in Q2 2016 and held it in 7 quarters.
  • Dean Investment Associates's Adtran position peaked at $5.46M in Q4 2017.
  • 158 funds tracked by Wall St. Rank held Adtran as of Q1 2018.

Based on Dean Investment Associates's 13F filing for Q1 2018, filed 9 May 2018.